Navigation Links
Onyx Pharmaceuticals Reports First Quarter 2011 Financial Results
Date:5/4/2011

n the fair value for the first quarter 2011 consisted of $6.1 million due to an increase in the assessed probability of technical and regulatory success (PTRS) and $5.4 million due to the passage of time. The increase in the PTRS was due to the expanded size and change in endpoint of the Phase 3 European clinical trial, referred to as FOCUS or the "011" trial, announced in March 2011.

Interest ExpenseInterest expense of $5.0 million for the first quarter 2011 primarily relates to the 4.0% convertible senior notes due 2016 issued in August 2009 and includes non-cash imputed interest expense of $2.4 million as a result of the application of ASC 470-20.

Other ExpenseOther expense for the first quarter 2011 primarily consists of a $3.0 million impairment charge which reflects the reassessment of the fair value of Onyx's equity investment in S*BIO.

Cash, Cash Equivalents and Marketable SecuritiesOn March 31, 2011, cash, cash equivalents, and current and non-current marketable securities were $561.7 million compared to $577.9 million at December 31, 2010.  This excludes restricted cash of $31.9 million at December 31, 2010.  

Management Conference Call TodayOnyx will host a teleconference and webcast to provide a general business overview and discuss financial results.  The event will begin at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) on May 4, 2011.  Interested parties may access a live webcast of the presentation on the company's website at:

http://www.onyx-pharm.com/investors/event-calendar

or by dialing 888-771-4371 within the U.S. or 847-585-4405 outside the U.S., and using the passcode 29609004#.  A replay of the presentation will be available on the Onyx website or by dialing 630-652-3042 and using the passcode 29609004# approximately one hour after the teleconference concludes for both US a
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Research and Markets  has announced the addition of ... report to their offering. The Central Nervous ... largest segments of pharmaceuticals industry. The numbers of CNS disorders ... were unable to meet the market requirements. There has been ... especially over the past two decades. The market for CNS ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
(Date:8/29/2014)... -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... release its financial results for the fiscal 2014 fourth ... trading ends on Tuesday, September 9, 2014. ... p.m. U.S. EDT on Tuesday, September 9, 2014 (Wednesday, ... Company,s financial results, commercial partnerships, and future outlook.  The ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
(Date:8/29/2014)... Mirada, CA (PRWEB) August 29, 2014 ... which will give patients the convenience of visiting ... with Healthpointe doctors through telemedicine. , Healthpointe doctors are ... calls (or audio). If necessary, the doctor can even ... assessed the patient’s condition, he or she can prescribe ...
(Date:8/29/2014)... Highly regarded audiologist , Dr. Mary Ann Larkin has ... four reports are titled:, , Revealing the Truth ... , The Top 5 Things You Should Know Before ... in Children , Dr. Mary Anne Larkin choose to ... confusion and misinformation about each them. The reports are available ...
(Date:8/29/2014)... TX (PRWEB) August 29, 2014 Carson ... website to provide hearing health care tips to local ... established blog section will offer weekly articles from the ... of topics including the latest advances in hearing restoration ... asked questions. The audiologists plan to write a new ...
(Date:8/29/2014)... Mental Health Commission of Canada identifies ways to ... police personnel receive. , "People with mental illnesses ... and today,s report builds on the increasingly collaborative ... illnesses," says Queen,s adjunct professor Dorothy Cotton, a ... of police psychology. "This is a gap-analysis tool ...
(Date:8/29/2014)... 2014) A team of scientists from the University ... discovery of a process to expand production of stem ... have implications that extend beyond cancer, including treatments for ... an article published Aug. 29 in ... Center for Regenerative Medicine and Stem Cell Biology and ...
Breaking Medicine News(10 mins):Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Report advocates improved police training 2Health News:CU scientists' discovery could lead to new cancer treatment 2
... Va., April 1 Thermage by ThermaCool was introduced ... Using novel technology to administer radiofrequency energy to the ... subsequent skin tightening. It is used predominantly on ... also available.Thermage initially showed less than optimal results. ...
... Day VILLANOVA, Pa. and 15 Centers Nationwide, April 1 ... of an autism diagnosis is four times that of girls. ... cancer, diabetes and AIDS combined, yet startlingly, many parents don,t know ... children or where to turn for help when those signs are ...
... Study in monkeys finds that it reduces replication of ... An investigational drug might help people with HIV who ... suggests. , Currently, the "gold standard" treatment for ... therapy, which consists of a number of drugs that ...
... Medicare beneficiaries who need physical therapist services ... obtain treatment under legislation introduced yesterday in the ... to Physical Therapists Act (HR 1829), introduced by ... Tammy Baldwin (D-WI), eliminates the need for beneficiaries ...
... financial guidance geared toward womenCENTERVILLE, Va., April 1 ... women have an estimated 90 percent chance of sole ... many are unprepared for this undertaking. In response, author ... comprehensive, easy-to-read financial guide every woman should own. ...
... Albert Einstein College of Medicine of Yeshiva University have proposed ... brains of people with autism are structurally normal but dysregulated, ... , The central tenet of the theory, published in the ... autism is a developmental disorder caused by impaired regulation of ...
Cached Medicine News:Health News:New Protocols Demonstrate Dramatic Improvement in Thermage Efficacy and Safety 2Health News:National Experts Offer Practical Tips for Parents Concerned about Autism 2Health News:National Experts Offer Practical Tips for Parents Concerned about Autism 3Health News:New HIV Drug May Help Those Resistant to Therapy 2Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 2Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 3Health News:Inspired by His Mother's Financial Hardship, Author Strives to Help Women Avoid Similar Mistakes 2Health News:Einstein scientists propose new theory of autism 2Health News:Einstein scientists propose new theory of autism 3
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
... Design for Unparalleled Comfort Pick one of ... balance. Notice the trigger and ejector positionsright where ... our pipettors are ergonomically designed to help avoid ... pipetting. Productivity In The Palm Of Your ...
... Finnpipette BioControl multichannel has the ... single channel model. The same ... multichannel and five single channel ... have a recharge and storage ...
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
Medicine Products: